Initial treatment of respiratory distress syndrome with nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure: A randomized controlled trial

International Journal of Preventive Medicine

Volumn 5, Issue 12, 2014, Pages 1543-1551

  Armanian, Amir Mohammad ^a   Badiee, Zohreh ^a   Heidari, Ghobad ^b   Feizi, Awat ^b   Salehimehr, Nima ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Almahdi University   (Iran)

Author keywords

Nasal CPAP; Noninvasive ventilation; Premature infants; Respiratory distress syndrome; Surfactant

Indexed keywords

SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BODY WEIGHT; CONTROLLED STUDY; ENDOTRACHEAL TUBE; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE; NASAL INTERMITTENT MANDATORY VENTILATION; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SAFETY; TREATMENT DURATION; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 84920998271     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Seki K, Iwasaki S, An H, Horiguchi H, Mori M, Nishimaki S, et al. Early discharge from a neonatal intensive care unit and rates of readmission. Pediatr Int 2011;53:7-12.
2. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2008 period linked birth/infant death data set. Natl Vital Stat Rep 2012;60:1-27.
3. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: A randomized, controlled, prospective study. J Pediatr 2007;150:521-6, 5261.
4. Thomson MA, IFDAS Study Group. Early nasal continuous positive pressure with prophylactic surfactant for neonates at risk of RDS. The IFDAS Multi-Center randomized trial. Pediatr Res 2002;51:379A.
5. Polin RA, Sahni R. Newer experience with CPAP. Semin Neonatol 2002;7:379-89.
6. Meneses J, Bhandari V, Alves JG, Herrmann D. Noninvasive ventilation for respiratory distress syndrome: A randomized controlled trial. Pediatrics 2011;127:300-7.
7. Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr 2009;98:1400-8.
8. Ammari A, Suri M, Milisavljevic V, Sahni R, Bateman D, Sanocka U, et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005;147:341-7.
9. Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2000;CD002271.
10. De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health 2001;37:161-7.
11. Owen LS, Morley CJ, Davis PG. Neonatal nasal intermittent positive pressure ventilation: A survey of practice in England. Arch Dis Child Fetal Neonatal Ed 2008;93:F148-50.
12. Verder H. Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatr 2007;96:482-4.
13. Dunn MS, Reilly MC. Approaches to the initial respiratory management of preterm neonates. Pediatric Respir Rev 2003;4:2-8.
14. Goldsmith, JP., Karotkin E. Assisted Ventilation of the Neonate: Expert Consult. Elsevier Health Sciences, 5th ed. 2010.
15. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003;CD000143.
16. Kishore MS, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatrica 2009;98:1412-5.
17. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics 1999;103:24.
18. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007;27:422-7.
19. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: A randomized, controlled trial. Pediatrics 2009;123:137-42.
20. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks’ gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: A randomized controlled trial. J Perinatol 2005;25:703-8.
21. Bohlin K, Jonsson B, Gustafsson AS, Blennow M. Continuous positive airway pressure and surfactant. Neonatology 2008;93:309-15.
22. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome (Cochrane review). Cochrane Database Syst Rev 2007;4:CD003063.
23. Jeena P, Pillay P, Adhikari M. Nasal CPAP in newborns with acute respiratory failure. Ann Trop Paediatr 2002;22:201-7.
24. Kamper J, Feilberg Jørgensen N, Jonsbo F, Pedersen-Bjergaard L, Pryds O, Danish ETFOL Study Group. The Danish national study in infants with extremely low gestational age and birthweight (theETFOL study): Respiratory morbidity and outcome. Acta Paediatr 2004;93:225-32.
25. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks’ gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: A randomized controlled trial. J Perinatol 2005;25:703-8.
26. Aly H, Massaro AN, Patel K, El-Mohandes AA. Is it safer to intubate premature infants in the delivery room? Pediatrics 2005;115:1660-5.
27. Andersen T, Holm HS, Kamper J. Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment. Ugeskr Laeger 2006;168:3723-7.
28. Friedlich P, Lecart C, Posen R, Ramicone E, Chan L, Ramanathan R. A randomized trial of nasopharyngeal-synchronized intermittent mandatory ventilation versus nasopharyngeal continuous positive airway pressure in very low birth weight infants after extubation. J Perinatol 1999;19:413-8.
29. Bhandari V, Gavino RG, Nedrelow JH, Pallela P, Salvador A, Ehrenkranz RA, et al. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. J Perinatol 2007;27:697-703.
30. Bhandari V. Nasal intermittent positive pressure ventilation in the newborn: Review of literature and evidence-based guidelines. J Perinatol 2010;30:505-12.
31. Davis PG, Morley CJ, Owen LS. Non-invasive respiratory support of preterm neonates with respiratory distress: Continuous positive airway pressure and nasal intermittent positive pressure ventilation. Semin Fetal Neonatal Med 2009;14:14-20.
32. Barrington KJ, Bull D, Finer NN. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics 2001;107:638-41.
33. Khalaf MN, Brodsky N, Hurley J, Bhandari V. A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics 2001;108:13-7.
34. De Paoli AG, Davis PG, Lemyre B. Nasal continuous positive airway pressure versus nasal intermittent positive pressure ventilation for preterm neonates: A systematic review and meta-analysis. Acta Paediatr 2003;92:70-5.
35. Lin CH, Wang ST, Lin YJ, Yeh TF. Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity. Pediatr Pulmonol 1998;26:349-53.
36. Lemyre B, Davis PG, de Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database Syst Rev 2002;CD002272.
37. Aghai ZH, Saslow JG, Nakhla T, Milcarek B, Hart J, Lawrysh-Plunkett R, et al. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP). Pediatr Pulmonol 2006;41:875-81.
38. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
39. Van Marter LJ, Allred EN, Ulana Sanocka MP, Marianne Moore RP, Nigel Paneth MS, Leviton A. “Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?.” Pediatrics 2000;105:1194-201.
40. Kero PO, Mäkinen EO. Comparison between clinical and radiological classification of infants with the respiratory distress syndrome (RDS). Eur J Pediatr 1979;130:271-8.
41. Wilkinson D, Andersen C, O’Donnell CP, De Paoli AG High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev 2011:CD006405.
42. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9.
43. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.